will take place next Winners will be announced in March, and its objectives are to increase and update knowledge about biosimilar medicines, their scientific bases, the regulatory requirements for their development and approval, and key concepts such as interchangeability. Registration is free and can be formalized at this link.
recently published
Horizon scanning
Jan 31 2024
Early Treatment: the role of biosimilars
18 2023 December
